Article

Bioinformatics in personalized medicine: Providing tailored healthcare

Published on October 15, 2024 | 5 min read
bioinformatics-personalized

Key takeaways

  • Bioinformatics is revolutionizing personalized medicine by enabling large datasets to be analyzed and treatment options to be tailored around a patient’s unique genetic makeup
  • Integrating artificial intelligence (AI) and machine learning (ML) into bioinformatics enhances data analysis efficiency and predictive accuracy
  • Bioinformatics will be key in advancing personalized medicine, providing insights into disease mechanisms and potential therapeutic targets

Recent technological advances within the world of healthcare have helped usher in a new era of personalized medicine. Thanks to the rise of bioinformatics in personalized medicine, it’s now possible to analyze large amounts of data and completely revolutionize the scope of possibilities when delivering tailored medical care.1

At Healthcare Transformers, we are incredibly excited about the potential benefits that using bioinformatics in personalized medicine can offer. Join us as we explore how bioinformatics can transform healthcare and provide tailored treatment options to patients.

What is bioinformatics?

Bioinformatics is a relatively new and evolving discipline that combines the fields of biology, computer science, and IT to enable the processing, analysis, and interpretation of biological data.2-4

The use of bioinformatics looks set to help shape the future of healthcare in a variety of ways, including its role in drug discovery, the diagnosis and prevention of disease, and the management of certain health conditions.3 However, one of the most exciting areas bioinformatics is associated with is personalized medicine — an emerging field of healthcare that aims to provide patients with tailored treatments based on their unique genetic makeup, breaking away from the “one size fits all” concept.1,5

Thanks to the ability of bioinformatics tools to analyze large sets of genomic and clinical data, researchers and clinicians can now identify the underlying genetic causes of diseases much more easily, allowing them to tailor their recommended treatments accordingly.3 This, in turn, has the potential to revolutionize the way we can diagnose and treat various conditions, including cancer.1

bioinformatics-personalized

The role of artificial intelligence and machine learning in bioinformatics

Artificial intelligence (AI) and machine learning (ML) are helping transform the world of healthcare in various ways. 

Thanks to recent advances, AI and ML are not only making it possible to improve the accuracy of predictive healthcare but also analyze complex biological data a lot more efficiently.6,7 This, in turn, has helped facilitate detailed insights into disease mechanisms and potential treatment plans, helping achieve the goal of making high-quality healthcare more affordable.5,7

For instance, AI-powered bioinformatics tools can help predict patient responses to specific therapies while also allowing providers to tailor treatments around individual patient needs.8

Meanwhile, ML — a subset of AI — is enabling computers to make these predictions without the need for explicit programming, and its algorithms are being increasingly used to not only analyze genomic data but also predict disease outcomes and identify potential drug targets.7

Being able to process large datasets in this way, with both AI and ML models, can uncover hidden patterns and correlations that may have been missed otherwise, helping deliver more successful personalized treatment plans to patients.6-8

Bioinformatics tools and applications in personalized medicine

The integration of AI and ML in bioinformatics is helping to enhance personalized medicine by leveraging advanced tools and methodologies that can deliver tailored healthcare solutions. By furthering our understanding of the genomic makeup of diseases, for instance, it is now possible to create more targeted therapies that are much more effective than the treatments currently available. 

Some key examples of the bioinformatics tools currently being used across the healthcare landscape include:

  • Sequence alignment tools — these tools can be used to align any number of protein sequences to help identify genetic mutations and variations that may impact a patient’s health.9 They also offer an effective way of identifying the genetic mutations and variations that may impact a patient’s health, thanks to their ability to identify homologous genes and proteins across different organisms10
  • Gene expression analysis tools — these tools are utilized to perform a quick analysis of RNA sequencing data, helping measure gene activity and identify potential therapeutic targets.11 They can also be used to help researchers explore the biology of individual cells in complex tissues in a highly specific manner12
  • Protein structure prediction tools — these tools can be employed to predict the 3D structures of proteins, facilitating insights into their functions and interactions and supporting potential drug discovery.13 With support from protein prediction tools, researchers can now obtain three-dimensional protein structural models to further understand how specific proteins work within certain diseases, such as those associated with protein misfolding mechanisms14
  • Molecular interaction visualization tools — these tools can be used to help visualize complex molecular networks and to help understand the interactions between different molecules, offering further insights into complex biological processes.15 Using various advances in computer graphics, these tools allow complex 2D or 3D molecular structures to be presented more intuitively and interactively, allowing researchers to improve their understanding of certain key factors, such as atomic spatial arrangements and the connectivity of chemical bonds16

Bioinformatics in personalized medicine: An ongoing revolution

The field of bioinformatics is continuously evolving, with new tools and techniques being developed to enhance the accuracy and efficiency of data analysis. 

Through the integration of AI and ML, bioinformatics tools are already helping to provide valuable insights into disease mechanisms and patient-specific responses to treatments.7 At the same time, this ongoing revolution is allowing healthcare to transition towards personalized medicine, tailoring treatments around a patient’s specific genetic makeup and personal information.
By continuing to leverage bioinformatics in this way, providers will soon be able to develop more effective treatment plans, offer improved patient care, and reduce healthcare costs.1,5 Therefore, as we continue to learn more about the genetic and molecular causes of disease, the use of bioinformatics in personalized medicine will continue to transform the quality of care that patients receive.1

Get our latest insights

Join our community and stay up to date with the latest laboratory innovations and insights.

Contributors

Rachel Marley headshot

Rachel Marley, MSci Chief Editor at LabLeaders.roche.com

Rachel Marley is the Chief Editor of LabLeaders at Roche Diagnostics, dedicated to delivering high-quality content that inspires and informs readers about laboratory innovation, empowering them to shape the future of laboratory science.

Newsletter for healthcare leaders and experts

Written for experts by experts, we offer the healthcare newsletter of choice when it comes to leading healthcare transformation.

Healthcare Transformers delivers insights on digital health, patient experience, healthcare business, value-based care, and data privacy and security—key topics and emerging trends facing healthcare leaders today. Collaborating with esteemed industry experts and innovators worldwide, we offer content that helps you gain first-hand knowledge, explore challenges, and think through solutions on the most pressing developments and issues. Subscribe to our Healthcare Transformers newsletter today and get critical discussions and invaluable perspectives delivered straight to your inbox.

References

  1. Cellappa V. (2023). Article available from https://www.linkedin.com/pulse/potential-bioinformatics-precision-edicine-venkatesh-chellappa/ [Accessed September 2024]
  2. Genomics Education Programme. Article available from https://www.genomicseducation.hee.nhs.uk/education/core-concepts/what-is-bioinformatics/ [Accessed September 2024]
  3. Viramgama N. (no date). Article available from https://mypharmavision.com/pharmacy-exams/pebc/bioinformatics-the-key-to-the-future-of-health-science/ [Accessed September 2024]
  4. Singh S et al. (2024). Adv Protein Chem Struct Biol. 139, 1–25. Paper available from https://www.sciencedirect.com/science/article/abs/pii/S1876162323000998 [Accessed September 2024]
  5. Sefanicka-Wojtas D, Kurpas D. (2023). J Pers Med. 13, 380. Paper available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058568/ [Accessed September 2024]
  6. Zheng P et al. (2024). Article available from https://www.frontiersin.org/research-topics/60099/artificial-intelligence-in-bioinformatics-and-genomics [Accessed September 2024]
  7. Javaid M. (2022). Int J Intelligent Networks 3, 58–73. Paper available from https://www.sciencedirect.com/science/article/pii/S2666603022000069 [Accessed September 2024]
  8. Singh A et al. (2023). Biomed Pharmacother 163, 114784. Paper available from https://www.sciencedirect.com/science/article/pii/S0753332223005735 [Accessed September 2024]
  9. European Molecular Biology Laboratory. (2023). Article available from https://www.ebi.ac.uk/jdispatcher/msa/clustalo [Accessed September 2024]
  10. Pearson W. (2013). Curr Protoc Bioinformatics., 3:3.1.1-3.1.8. Paper available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820096/ [Accessed October 2024]
  11. Prieto C et al. (2020). Bioinformatics 36, 1955–1956. Paper available from https://academic.oup.com/bioinformatics/article/36/6/1955/5626181?login=false [Accessed September 2024]
  12. Illumina. (no date). Article available from https://emea.illumina.com/techniques/multiomics/transcriptomics/gene-expression-analysis.html [Accessed October 2024]
  13. Jumper J et al. (2021). Nature 596, 583–589. Paper available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371605/ [Accessed September 2024]
  14. Wang J. (2016). Adv Exp Med Biol. 939, 39–61. Paper available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829626/ [Accessed October 2024]
  15. Shannon P et al. (2003). Genome Res 13, 2498–2504. Paper available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC403769/ [Accessed September 2024]
  16. Li H et al. (2024). Curr Issues Mol Biol. 46, 1318-1334. Paper available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10887528/ [Accessed October 2024]